Larimar Therapeutics (LRMR) Return on Assets (2014 - 2025)

Larimar Therapeutics' Return on Assets history runs 12 years deep, the most recent figure standing at 0.01% for Q4 2025.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
• Return on Assets was 0.01% for Q4 2025 at Larimar Therapeutics, up from 0.02% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q2 2024 and bottomed at 0.04% in Q1 2021.
• A 5-year average of 0.02% and a median of 0.02% in 2022 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 33 bps in 2021, while the deepest fall reached 3 bps in 2021.
• Larimar Therapeutics' Return on Assets stood at 0.02% in 2021, then jumped by 41 bps to 0.01% in 2022, then plunged by 44 bps to 0.02% in 2023, then surged by 30 bps to 0.01% in 2024, then advanced by 21 bps to 0.01% in 2025.
• Business Quant data shows LRMR's Return on Assets at 0.01% in Q4 2025, 0.02% in Q3 2025, and 0.02% in Q2 2025.